Zenotech Laboratories Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 61.03 Cr
as on 17-11-2024
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 Cr
as on 17-11-2024
- Satisfied Charges ₹ 64.71 Cr
as on 17-11-2024
- Revenue 16.97%
(FY 2023)
- Profit -47.76%
(FY 2023)
- Ebitda 18.57%
(FY 2023)
- Net Worth 16.46%
(FY 2023)
- Total Assets 7.22%
(FY 2023)
About Zenotech Laboratories
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532039.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 61.03 Cr.
The company currently has active open charges totaling ₹6.00 Cr. The company has closed loans amounting to ₹64.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Zenotech Laboratories Limited India are Sachin Gavandare as Ceo, Abdul Mohammad as Company Secretary, and Kachappilly Varghese as Cfo. Chintan Shah, Rakeshchandra Sinha, Kavita Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
L27100TG1989PLC010122
- Company No.
010122
- Stock Symbol
BSE : 532039
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Jun 1989
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Zenotech Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sachin Gavandare | CEO | 07-Nov-2024 | Current |
Abdul Mohammad  | Company Secretary | 11-Mar-2016 | Current |
| Kachappilly Varghese | CFO | 26-May-2015 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakeshchandra Sinha | Director | 01-Feb-2020 | Current |
| Jagruti Sheth | Director | 01-Feb-2020 | Current |
| Chintan Shah | Director | 27-Jan-2016 | Current |
| Azadar Khan | Director | 25-Aug-2015 | Current |
| Kavita Shah | Director | 01-Apr-2015 | Current |
| Jignesh Goradia | Director | 08-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Zenotech Laboratories.
Zenotech Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.97% increase. The company also saw a substantial fall in profitability, with a 47.76% decrease in profit. The company's net worth Soared by an impressive increase of 16.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenotech Laboratories?
In 2023, Zenotech Laboratories had a promoter holding of 68.84% and a public holding of 31.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Foundation For Disease Elimination And Control Of IndiaActive 8 years 2 monthsAzadar Khan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Technology Development Board Creation Date: 24 Oct 2005 | ₹6.00 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Mar 2012 | ₹15.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 17 Jan 2008 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Zenotech Laboratories?
Zenotech Laboratories has a workforce of 181 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenotech Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenotech Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
